Effect of Aspirin at the Acute Phase of Cerebral Ischemic Event. "Aspirin"


Phase N/A Results N/A

Summary of Purpose

Aspirin is the only anti-platelet medication used at the acute phase of ischemic stroke. The investigators would like to study laboratory effect of the first oral 300 mg dose of aspirin, given at hospital, after an ischemic event. The principal hypothesis is that platelet activity would be able to recover during this day and could lead to ischemic recurrences. Two blood samples are accomplished. The first...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 20 June 2011.

1 Dec 2010 16 Jun 2011 1 Jul 2011 Unavailable 1 Jun 2011 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics




Trial Design

  • Masking: Open Label
  • Purpose: Treatment
  • Endpoint: Pharmacokinetics/Dynamics Study
  • Intervention: Single Group Assignment